Estimation of renin and D-dimer levels in women with polycystic ovary disease with or without coronavirus infection
Keywords:COVID-19, follicle-stimulating hormone, FSH, PCOS
Background and objective: Polycystic ovarian syndrome (PCOS) is a common endocrinologic disorder among women of childbearing age. Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed to determine the levels of renin, d-dimer, and some relevant biomarkers in patients with PCOS (with and without COVID-19) compared with non-PCOS patients (with and without COVID-19).
Methods: This cross-sectional study included 120 women [80 PCOS women (40 with COVID-19 and 40 without COVID-19) and 40 non-PCOS women (20 with COVID-19 and 20 without)] with age range of 15–40 years old. Blood samples were collected from participants, and biochemical assays were carried out. Renin and d-dimer levels were determined using the enzyme-linked-immunosorbent-assay (ELISA), lipid-profile and fasting blood glucose concentrations were assessed by using the colorimetric methods, and hormones were evaluated by VIDAS.
Results: Renin and d-dimer levels were found to be significantly higher in PCOS-women groups compared to non-PCOS group. In addition, the results showed that hormones, fasting blood glucose, and lipid-profile are significantly increased in PCOS patients compared to non-PCOS women, while high-density-lipoprotein and follicle-stimulating-hormone levels were low when comparing PCOS patients with non-PCOS ones. The results also showed that a highly significant increase in renin and d-dimer levels can be detected in PCOS patients with COVID-19.
Conclusions: In the present study, we found there is a possible relationship between renin and d-dimer in PCOS patients who are also COVID-19 infected.
A Cignarelli et al. “Insulin and insulin Receptors in adipose tissue development”. Int J Mol Sci 20(3) (2019), pp. 759–759. DOI: 10.3390/ijms20030759.
A Dokras et al. “Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS”. J Clin Endocrinol Metab 101(8) (2016), pp. 2966–2974. DOI: 10.1210/jc.2016-1896.
A Eqbal and Iaahfaae Gatea. “Effect of polycystic ovarian Syndrome on the lipid profile and sexual hormones”. J Pharm Sci Res 11(5) (2019), pp. 2048–2050.
A G Kebapcilar, C E Taner, and I Sari. “High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome”. Arch Gynecol Obstet 280(2) (2009), pp. 187–193. DOI: 10.1007/s00404-008-0884-0.
A Goren et al. “A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain – A potential clue to the role of androgens in COVID-19 severity”. J Cosmet Dermatol 19(7) (2020), pp. 1545–1552. DOI: 10.1111/jocd.13443.
A Lehmann et al. “Impact of persistent D-dimer elevation following recovery from COVID-19”. PLoS One 16 (2021). DOI: 10.1371/journal.pone.0258351.
A Soni, S Singla, and S Goyal. “Polycystic ovary syndrome: Pathogenesis, treatment and secondary associated diseases”. J Drug Deliv Therap 8(5) (2018), pp. 107–119. DOI: 10.22270/jddt.v8i5.1892.
Asm Moin et al. “Vitamin D association with macrophage-derived cytokines in polycystic ovary syndrome: An enhanced risk of COVID-19 infection?” Front Endocrinol (Lausanne) 12 (2021). DOI: 10.3389/fendo.2021.638621.
Batool Mutar Mahdi. “COVID-19 vaccine hesitancy and acceptance among medical students: An online cross-sectional study in Iraq”. Open Access Maced J Med Sci 9(A) (2021), pp. 955–958. DOI: 10.3889/oamjms.2021.7399.
Guan W Jie et al. “Clinical characteristics of coronavirus disease 2019 in China”. N Eng J Med 382(18) (2020), pp. 1708–1728. DOI: 10.1056/NEJMoa2002032.
H Watanabe et al. “Renin cell baroreceptor, a nuclear mechanotransducer central for homeostasis”. Circ Res 129(2) (2009), pp. 262–76. DOI: 10.1161/CIRCRESAHA.120.318711.
I Kyrou et al. “Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic”. BMC Med 18(1) (2020), pp. 220–220. DOI: 10.1186/s12916-020-01697-5.
Israa F. Ascar and Areej Sh. Hameed. “Serum prolactin, preptin, CCL 18 and genetic polymorphisms in Iraqi women with polycystic ovary syndrome”. Baghdad Sci J 18(4) (2021), pp. 1552–1556. DOI: 10.21123/bsj.2021.18.4(Suppl.).1552.
K Doroszewska et al. “Blood pressure in postmenopausal women with a history of polycystic ovary syndrome”. Menopausal Rev 18(2) (2019), pp. 94–102. DOI: 10.5114/pm.2019.84039.
L A Sechi et al. “Relationship of plasma renin with a prothrombotic state in hypertension: Relevance for organ damage”. Am J Hypertens 21(12) (2008), pp. 1347–1353. DOI: 10.1038/ajh.2008.293.
Mme Ollila et al. “Overweight and obese but not normal weight women with PCOS is at increased risk of type 2 diabetes mellitus-a prospective, population-based cohort study”. Hum Reprod 32 (2017), pp. 423–454. DOI: 10.1093/humrep/dew329.
N A Siddiqui et al. “A potential solution to problems of cancer screening, surveillance, and prognosis assessment”. Cureus 13(5) (2021). DOI: 10.7759/cureus.15064.
Nabigh A. Naji, Shatha H. Ali, and Fatin S. Farhan. “Correlation between serum carnitine level and soluble receptors for advance glycation end products (sRAGE) in clomiphene citrate resistant-PCOS women”. Iraqi J Pharm Sci 30(1) (2021), pp. 110–121. DOI: 10.31351/vol30iss1pp110-121.
S Harnois-Leblanc et al. “Profile of daughters and sisters of women with polycystic ovary syndrome: The role of proband’s glucose tolerance”. J Clin Endocrinol Meta 107(3) (2022), e912–923. DOI: 10.1210/clinem/dgab812.
S Hashemi et al. “Association of PCOS and its clinical signs with sexual function among Iranian women affected by PCOS”. J Sex Med 11(10) (2014), pp. 2508–2522. DOI: 10.1111/jsm.12627.
Shaimaa Emad Ali, Fayhaa M. Khaleel, and Farah Emad Ali. “A study of apelin-36 and GST levels with their relationship to lipid and other biochemical parameters in the prediction of heart diseases in PCOS women patients”. Baghdad S J 17(3) (2020), pp. 54–64. DOI: 10.21123/bsj.2020.17.3(Suppl.).0924.
Suhayla K. Mohammed, Muzahem Mohialdeen Taha, and Ekhlass M. Taha. “Cluster analysis of biochemical markers as predictor of COVID-19 severity”. Baghdad Sci J 19(6) (2022), pp. 1423–1429. DOI: 10.21123/bsj.2022.7454.
Ting Ding et al. “Potential influence of menstrual status and sex hormones on female severe acute respiratory syndrome coronavirus 2 infection: A cross-sectional multicenter study in Wuhan, China”. Clin Infect Dis 72(9) (2022), e240–e248. DOI: 10.1093/cid/ciaa1022.
U Julius et al. “COVID-19 and lipid disorders”. Horm Metab Res 54 (2022), pp. 514–535. DOI: 10.1055/a-1860-2610.
U Shahera et al. “A comprehensive literature review on the pandemic coronavirus disease 2019 (COVID-19): Bangladesh is fighting against it”. Am J Biomed Life Sci 8(4) (2020), pp. 76–76. DOI: 10.11648/j.ajbls.20200804.13.
Z Zhang, H Liu, and J Liu. “Akt activation: A potential strategy to ameliorate insulin resistance”. Diabetes Res Clin Pract 156 (2019), pp. 107092–107092. DOI: 10.1016/j.diabres.2017.10.004.
Copyright (c) 2022 Shaimaa E. Ali, Fayhaa M. Khaleel, Farah E. Ali
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors retain all proprietary rights, including copyright, such as patent and trade mark rights and rights to any process or procedure described in the article.